Green Cross Cell rises 0.35% amid umbilical cord blood theme uptrend

On the 11th, the cord blood theme rose 4.01% compared to the previous day, showing strength, while Green Cross Cell, which is attracting attention as a related stock, surged 0.35% compared to the previous day. Green Cross Cell is known as a developer and manufacturer of anticancer immune cell therapies.

[Graph] Major stock price changes in the cord blood theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Green Cross Cell's quant financial score is 24.1 points, with higher stability and profitability scores than the average of other cord blood-related stocks, but its quant financial ranking was only 4th out of 7 stocks. On the other hand, Green Cross achieved the 1st place in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.